Envestnet Portfolio Solutions, Inc.
Position in PTCT — Ptc Therapeutics, Inc.
CIK 1998033
BERWYN, PA
Position in PTCT
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,119,956
+$200,678 QoQ
Shares Held
13,730
+1.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#173
of 380 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Envestnet Portfolio Solutions, Inc. holds $15,944,229 across 18 Biotechnology names. PTCT ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,064 | $4,005,630 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,030 | $1,934,989 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,635 | $1,395,274 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
21,192 | $1,164,288 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
This page
|
13,730 | $1,119,956 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
10,617 | $923,148 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
11,409 | $892,982 | |
| 8 | 21,996 | $691,334 |
All Filings in PTCT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,119,956 | 13,730 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $919,278 | 13,493 | Shares | Sole | 2026-04-29 | |
| 2025-09-30 | $211,971 | 3,454 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||